(Patho-)physiological relevance of PINK1-dependent ubiquitin phosphorylation

Fabienne C. Fiesel, Maya Ando, Roman Hudec, Anneliese R. Hill, Monica Castanedes-Casey, Thomas R. Caulfield, Elisabeth L. Moussaud-Lamodière, Jeannette N. Stankowski, Peter O. Bauer, Oswaldo Lorenzo-Betancor, Isidre Ferrer, José M. Arbelo, Joanna Siuda, Li Chen, Valina Dawson, Ted M Dawson, Zbigniew K. Wszolek, Owen A. Ross, Dennis W. Dickson, Wolfdieter Springer

Research output: Contribution to journalArticle

Abstract

Mutations in PINK1 and PARKIN cause recessive, early-onset Parkinson's disease (PD). Together, these two proteins orchestrate a protective mitophagic response that ensures the safe disposal of damaged mitochondria. The kinase PINK1 phosphorylates ubiquitin (Ub) at the conserved residue S65, in addition to modifying the E3 ubiquitin ligase Parkin. The structural and functional consequences of Ub phosphorylation (pS65-Ub) have already been suggested from in vitro experiments, but its (patho-)physiological significance remains unknown. We have generated novel antibodies and assessed pS65-Ub signals in vitro and in cells, including primary neurons, under endogenous conditions. pS65-Ub is dependent on PINK1 kinase activity as confirmed in patient fibroblasts and postmortem brain samples harboring pathogenic mutations. We show that pS65-Ub is reversible and barely detectable under basal conditions, but rapidly induced upon mitochondrial stress in cells and amplified in the presence of functional Parkin. pS65-Ub accumulates in human brain during aging and disease in the form of cytoplasmic granules that partially overlap with mitochondrial, lysosomal, and total Ub markers. Additional studies are now warranted to further elucidate pS65-Ub functions and fully explore its potential for biomarker or therapeutic development. Synopsis In this study, two newly generated antibodies are used to detect endogenous phospho-ubiquitin in cells and human brain samples. pS65-Ub is shown to be reversible, respond to mitochondrial stress and accumulate during aging and in Parkinson's disease (PD). pS65-Ub is amplified by the concerted action of PINK1 kinase and Parkin E3 ubiquitin ligase in response to mitochondrial stress. pS65-Ub specifically labels severely damaged mitochondria destined for degradation. pS65-Ub is a novel biomarker of mitochondrial quality control and could also serve as a potential therapeutic target for PD. In this study, two newly generated antibodies are used to detect endogenous phospho-ubiquitin in cells and human brain samples. pS65-Ub is shown to be reversible, respond to mitochondrial stress and accumulate during aging and in Parkinson's disease.

Original languageEnglish (US)
Pages (from-to)1114-1130
Number of pages17
JournalEMBO Reports
Volume16
Issue number9
DOIs
StatePublished - Sep 1 2015

Fingerprint

Phosphorylation
Ubiquitin
Parkinson Disease
Brain
Mitochondria
Ubiquitin-Protein Ligases
Phosphotransferases
Aging of materials
Biomarkers
Antibodies
Cytoplasmic Granules
Mutation
Fibroblasts

Keywords

  • early-onset Parkinson's disease
  • mitophagy
  • Parkin
  • phosphorylated ubiquitin
  • PINK1

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology
  • Biochemistry

Cite this

Fiesel, F. C., Ando, M., Hudec, R., Hill, A. R., Castanedes-Casey, M., Caulfield, T. R., ... Springer, W. (2015). (Patho-)physiological relevance of PINK1-dependent ubiquitin phosphorylation. EMBO Reports, 16(9), 1114-1130. https://doi.org/10.15252/embr.201540514

(Patho-)physiological relevance of PINK1-dependent ubiquitin phosphorylation. / Fiesel, Fabienne C.; Ando, Maya; Hudec, Roman; Hill, Anneliese R.; Castanedes-Casey, Monica; Caulfield, Thomas R.; Moussaud-Lamodière, Elisabeth L.; Stankowski, Jeannette N.; Bauer, Peter O.; Lorenzo-Betancor, Oswaldo; Ferrer, Isidre; Arbelo, José M.; Siuda, Joanna; Chen, Li; Dawson, Valina; Dawson, Ted M; Wszolek, Zbigniew K.; Ross, Owen A.; Dickson, Dennis W.; Springer, Wolfdieter.

In: EMBO Reports, Vol. 16, No. 9, 01.09.2015, p. 1114-1130.

Research output: Contribution to journalArticle

Fiesel, FC, Ando, M, Hudec, R, Hill, AR, Castanedes-Casey, M, Caulfield, TR, Moussaud-Lamodière, EL, Stankowski, JN, Bauer, PO, Lorenzo-Betancor, O, Ferrer, I, Arbelo, JM, Siuda, J, Chen, L, Dawson, V, Dawson, TM, Wszolek, ZK, Ross, OA, Dickson, DW & Springer, W 2015, '(Patho-)physiological relevance of PINK1-dependent ubiquitin phosphorylation', EMBO Reports, vol. 16, no. 9, pp. 1114-1130. https://doi.org/10.15252/embr.201540514
Fiesel FC, Ando M, Hudec R, Hill AR, Castanedes-Casey M, Caulfield TR et al. (Patho-)physiological relevance of PINK1-dependent ubiquitin phosphorylation. EMBO Reports. 2015 Sep 1;16(9):1114-1130. https://doi.org/10.15252/embr.201540514
Fiesel, Fabienne C. ; Ando, Maya ; Hudec, Roman ; Hill, Anneliese R. ; Castanedes-Casey, Monica ; Caulfield, Thomas R. ; Moussaud-Lamodière, Elisabeth L. ; Stankowski, Jeannette N. ; Bauer, Peter O. ; Lorenzo-Betancor, Oswaldo ; Ferrer, Isidre ; Arbelo, José M. ; Siuda, Joanna ; Chen, Li ; Dawson, Valina ; Dawson, Ted M ; Wszolek, Zbigniew K. ; Ross, Owen A. ; Dickson, Dennis W. ; Springer, Wolfdieter. / (Patho-)physiological relevance of PINK1-dependent ubiquitin phosphorylation. In: EMBO Reports. 2015 ; Vol. 16, No. 9. pp. 1114-1130.
@article{c44db32c352e462995765851d482dda3,
title = "(Patho-)physiological relevance of PINK1-dependent ubiquitin phosphorylation",
abstract = "Mutations in PINK1 and PARKIN cause recessive, early-onset Parkinson's disease (PD). Together, these two proteins orchestrate a protective mitophagic response that ensures the safe disposal of damaged mitochondria. The kinase PINK1 phosphorylates ubiquitin (Ub) at the conserved residue S65, in addition to modifying the E3 ubiquitin ligase Parkin. The structural and functional consequences of Ub phosphorylation (pS65-Ub) have already been suggested from in vitro experiments, but its (patho-)physiological significance remains unknown. We have generated novel antibodies and assessed pS65-Ub signals in vitro and in cells, including primary neurons, under endogenous conditions. pS65-Ub is dependent on PINK1 kinase activity as confirmed in patient fibroblasts and postmortem brain samples harboring pathogenic mutations. We show that pS65-Ub is reversible and barely detectable under basal conditions, but rapidly induced upon mitochondrial stress in cells and amplified in the presence of functional Parkin. pS65-Ub accumulates in human brain during aging and disease in the form of cytoplasmic granules that partially overlap with mitochondrial, lysosomal, and total Ub markers. Additional studies are now warranted to further elucidate pS65-Ub functions and fully explore its potential for biomarker or therapeutic development. Synopsis In this study, two newly generated antibodies are used to detect endogenous phospho-ubiquitin in cells and human brain samples. pS65-Ub is shown to be reversible, respond to mitochondrial stress and accumulate during aging and in Parkinson's disease (PD). pS65-Ub is amplified by the concerted action of PINK1 kinase and Parkin E3 ubiquitin ligase in response to mitochondrial stress. pS65-Ub specifically labels severely damaged mitochondria destined for degradation. pS65-Ub is a novel biomarker of mitochondrial quality control and could also serve as a potential therapeutic target for PD. In this study, two newly generated antibodies are used to detect endogenous phospho-ubiquitin in cells and human brain samples. pS65-Ub is shown to be reversible, respond to mitochondrial stress and accumulate during aging and in Parkinson's disease.",
keywords = "early-onset Parkinson's disease, mitophagy, Parkin, phosphorylated ubiquitin, PINK1",
author = "Fiesel, {Fabienne C.} and Maya Ando and Roman Hudec and Hill, {Anneliese R.} and Monica Castanedes-Casey and Caulfield, {Thomas R.} and Moussaud-Lamodi{\`e}re, {Elisabeth L.} and Stankowski, {Jeannette N.} and Bauer, {Peter O.} and Oswaldo Lorenzo-Betancor and Isidre Ferrer and Arbelo, {Jos{\'e} M.} and Joanna Siuda and Li Chen and Valina Dawson and Dawson, {Ted M} and Wszolek, {Zbigniew K.} and Ross, {Owen A.} and Dickson, {Dennis W.} and Wolfdieter Springer",
year = "2015",
month = "9",
day = "1",
doi = "10.15252/embr.201540514",
language = "English (US)",
volume = "16",
pages = "1114--1130",
journal = "EMBO Reports",
issn = "1469-221X",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - (Patho-)physiological relevance of PINK1-dependent ubiquitin phosphorylation

AU - Fiesel, Fabienne C.

AU - Ando, Maya

AU - Hudec, Roman

AU - Hill, Anneliese R.

AU - Castanedes-Casey, Monica

AU - Caulfield, Thomas R.

AU - Moussaud-Lamodière, Elisabeth L.

AU - Stankowski, Jeannette N.

AU - Bauer, Peter O.

AU - Lorenzo-Betancor, Oswaldo

AU - Ferrer, Isidre

AU - Arbelo, José M.

AU - Siuda, Joanna

AU - Chen, Li

AU - Dawson, Valina

AU - Dawson, Ted M

AU - Wszolek, Zbigniew K.

AU - Ross, Owen A.

AU - Dickson, Dennis W.

AU - Springer, Wolfdieter

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Mutations in PINK1 and PARKIN cause recessive, early-onset Parkinson's disease (PD). Together, these two proteins orchestrate a protective mitophagic response that ensures the safe disposal of damaged mitochondria. The kinase PINK1 phosphorylates ubiquitin (Ub) at the conserved residue S65, in addition to modifying the E3 ubiquitin ligase Parkin. The structural and functional consequences of Ub phosphorylation (pS65-Ub) have already been suggested from in vitro experiments, but its (patho-)physiological significance remains unknown. We have generated novel antibodies and assessed pS65-Ub signals in vitro and in cells, including primary neurons, under endogenous conditions. pS65-Ub is dependent on PINK1 kinase activity as confirmed in patient fibroblasts and postmortem brain samples harboring pathogenic mutations. We show that pS65-Ub is reversible and barely detectable under basal conditions, but rapidly induced upon mitochondrial stress in cells and amplified in the presence of functional Parkin. pS65-Ub accumulates in human brain during aging and disease in the form of cytoplasmic granules that partially overlap with mitochondrial, lysosomal, and total Ub markers. Additional studies are now warranted to further elucidate pS65-Ub functions and fully explore its potential for biomarker or therapeutic development. Synopsis In this study, two newly generated antibodies are used to detect endogenous phospho-ubiquitin in cells and human brain samples. pS65-Ub is shown to be reversible, respond to mitochondrial stress and accumulate during aging and in Parkinson's disease (PD). pS65-Ub is amplified by the concerted action of PINK1 kinase and Parkin E3 ubiquitin ligase in response to mitochondrial stress. pS65-Ub specifically labels severely damaged mitochondria destined for degradation. pS65-Ub is a novel biomarker of mitochondrial quality control and could also serve as a potential therapeutic target for PD. In this study, two newly generated antibodies are used to detect endogenous phospho-ubiquitin in cells and human brain samples. pS65-Ub is shown to be reversible, respond to mitochondrial stress and accumulate during aging and in Parkinson's disease.

AB - Mutations in PINK1 and PARKIN cause recessive, early-onset Parkinson's disease (PD). Together, these two proteins orchestrate a protective mitophagic response that ensures the safe disposal of damaged mitochondria. The kinase PINK1 phosphorylates ubiquitin (Ub) at the conserved residue S65, in addition to modifying the E3 ubiquitin ligase Parkin. The structural and functional consequences of Ub phosphorylation (pS65-Ub) have already been suggested from in vitro experiments, but its (patho-)physiological significance remains unknown. We have generated novel antibodies and assessed pS65-Ub signals in vitro and in cells, including primary neurons, under endogenous conditions. pS65-Ub is dependent on PINK1 kinase activity as confirmed in patient fibroblasts and postmortem brain samples harboring pathogenic mutations. We show that pS65-Ub is reversible and barely detectable under basal conditions, but rapidly induced upon mitochondrial stress in cells and amplified in the presence of functional Parkin. pS65-Ub accumulates in human brain during aging and disease in the form of cytoplasmic granules that partially overlap with mitochondrial, lysosomal, and total Ub markers. Additional studies are now warranted to further elucidate pS65-Ub functions and fully explore its potential for biomarker or therapeutic development. Synopsis In this study, two newly generated antibodies are used to detect endogenous phospho-ubiquitin in cells and human brain samples. pS65-Ub is shown to be reversible, respond to mitochondrial stress and accumulate during aging and in Parkinson's disease (PD). pS65-Ub is amplified by the concerted action of PINK1 kinase and Parkin E3 ubiquitin ligase in response to mitochondrial stress. pS65-Ub specifically labels severely damaged mitochondria destined for degradation. pS65-Ub is a novel biomarker of mitochondrial quality control and could also serve as a potential therapeutic target for PD. In this study, two newly generated antibodies are used to detect endogenous phospho-ubiquitin in cells and human brain samples. pS65-Ub is shown to be reversible, respond to mitochondrial stress and accumulate during aging and in Parkinson's disease.

KW - early-onset Parkinson's disease

KW - mitophagy

KW - Parkin

KW - phosphorylated ubiquitin

KW - PINK1

UR - http://www.scopus.com/inward/record.url?scp=84940776745&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940776745&partnerID=8YFLogxK

U2 - 10.15252/embr.201540514

DO - 10.15252/embr.201540514

M3 - Article

C2 - 26162776

AN - SCOPUS:84940776745

VL - 16

SP - 1114

EP - 1130

JO - EMBO Reports

JF - EMBO Reports

SN - 1469-221X

IS - 9

ER -